Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Heterologous SKYCovione Booster in Adults
NCT05501522Phase 3Completed
- Sponsor
- SK bioscience
- Start
- Dec 2022
- Primary completion
- Aug 2023
- Modality
- Nanoparticles, Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 3 trial of GBP510 in coronavirus disease 2019 (COVID-19), sponsored by SK bioscience. Started Dec 2022; status: completed.
02
Drugs
GBP510
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05501522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05501522.